Skip to main content

Table 2 Association of Chronic Kidney Disease and Apo-lipoprotein B in the study subjects (N = 8322)

From: Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey

Variable

Model 1c

Model 2c

Model 3c

Model 4c

Model 5c

ORa

1.78

1.48

1.39

1.28

1.29

(95% CIa)

(1.67, 1.89)

(1.38, 1.58)

(1.29, 1.49)

(1.14, 1.44)

(1.15, 1.45)

LRb

− 7784.8

− 6494.3

− 6307.2

− 6193.2

− 6156.3

Chi-Square (DF)

/

2581.00 (5)

374.30 (7)

227.90 (6)

73.83 (6)

t value

17.81

11.33

9.35

4.16

4.25

p (Apo B)

/

< 0.01

< 0.01

< 0.01

< 0.01

  1. aOR Odds ratio, CI Confidence interval
  2. b LR test wasperformed between model 1~model 2, model 2~model 3, model 3~model 4, and model4~model5; All the P value of LR is < 0.001
  3. cModel 1: Estimate without covariate
  4. Model 2: Adjusted for demographic characteristics (age, gender, body mass index, region and education)
  5. Model 3: Adjusted for model 2, nutrient status (fat intakes, protein intakes and calorie intakes) and comorbidities (Hyperuricemia, diabetes, anemia and hypertension)
  6. Model 4: Adjusted for model 3 and biochemical indicators (hemoglobin, albumin, apo-lipoprotein A, urea nitrogen, triglycerides, total cholesterol, high-density lipoprotein and low-density lipoprotein)
  7. Model 5: Adjusted for model 4 and life style (smoking, alcohol drinking, water drinking, tea drinking, screen view and sleeping duration)